Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically...

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Long non-coding RNAs (lncRNAs) regulate biological processes, and their dysregulation is implicated in cancer.
• Small Nucleolar RNA Host Gene 20 (SNHG20) overexpression is linked to poor prognosis in colorectal and hepatocellular carcinomas.
• The clinical significance and molecular mechanisms of SNHG20 in non-small cell lung cancer (NSCLC) remain largely undocumented.

Purpose of the Study:

• To investigate the clinical relevance and molecular mechanisms of SNHG20 in non-small cell lung cancer (NSCLC).
• To determine the association between SNHG20 expression and clinicopathological features and prognosis in NSCLC patients.

Main Methods:

• Quantitative real-time PCR to measure SNHG20 expression in NSCLC tissues and adjacent normal samples.
• Western blotting and cell-based assays (proliferation, migration, apoptosis) to assess the functional role of SNHG20.
• RNA immunoprecipitation and Western blotting to investigate the interaction between SNHG20, EZH2, and p21.

Main Results:

• SNHG20 was significantly upregulated in NSCLC tissues compared to normal tissues.
• Higher SNHG20 expression correlated with advanced TNM stage, larger tumor size, and poorer overall survival.
• Knockdown of SNHG20 inhibited NSCLC cell proliferation and migration while inducing apoptosis.
• SNHG20 directly interacted with EZH2 to suppress p21 expression, functioning as an oncogene in NSCLC.

Conclusions:

• SNHG20 is upregulated in NSCLC and associated with adverse clinical outcomes.
• SNHG20 promotes NSCLC progression by interacting with EZH2 and repressing p21.
• SNHG20 represents a potential biomarker for NSCLC diagnosis and prognosis, and a therapeutic target.